Figure 2.

Schema describing the potential induction of T-cell coinhibitory molecules as an unintended consequence of MAPK inhibition. In the proposed model, we suggest that MAPK inhibition may lead to the unintended upregulation of coinhibitory, immune checkpoint molecules on the surface of cancer and T cells alike, which may facilitate tumor escape from immune surveillance. mAb, monoclonal antibody.